Fbd Biologics Limited
Clinical trials sponsored by Fbd Biologics Limited, explained in plain language.
-
New drug HCB301 takes on tough cancers in early human trial
Disease control Recruiting nowThis early-phase study tests an investigational drug called HCB301 in adults with advanced solid tumors or classical Hodgkin lymphoma that has come back or not responded to other treatments. The main goals are to check safety, find the right dose, and see if the drug shrinks tumo…
Phase: PHASE1 • Sponsor: FBD Biologics Limited • Aim: Disease control
Last updated May 26, 2026 05:20 UTC
-
New drug HCB101 tested in patients with Tough-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called HCB101 in adults with advanced solid tumors or non-Hodgkin lymphoma that hasn't responded to standard treatments. The main goals are to check safety and find the right dose. About 80 participants will receive the drug through an IV t…
Phase: PHASE1 • Sponsor: FBD Biologics Limited • Aim: Disease control
Last updated May 15, 2026 11:54 UTC